These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Oncogenes and onco-suppressor genes in lung cancer. Anderson ML; Spandidos DA Respir Med; 1993 Aug; 87(6):413-20. PubMed ID: 8210611 [No Abstract] [Full Text] [Related]
3. Genetic changes in lung cancer: potential biomarkers for early detection and prevention. Crowell RE; Belinsky SA J Lab Clin Med; 1997 Dec; 130(6):550-7. PubMed ID: 9422328 [No Abstract] [Full Text] [Related]
4. Oncogenes and tumor suppressor genes involved in human lung carcinogenesis. Harris CC; Reddel R; Modali R; Lehman TA; Iman D; McMenamin M; Sugimura H; Weston A; Pfeifer A Basic Life Sci; 1990; 53():363-79. PubMed ID: 2282044 [No Abstract] [Full Text] [Related]
5. [Oncogenes, antioncogenes and carcinogenesis]. Kopnin BP Arkh Patol; 1990; 52(9):3-11. PubMed ID: 2270978 [TBL] [Abstract][Full Text] [Related]
6. Genetics of cancer predisposition and progression. Schwechheimer K; Cavenee WK Clin Investig; 1993 Jun; 71(6):488-502. PubMed ID: 8353410 [TBL] [Abstract][Full Text] [Related]
7. Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer. Viallet J; Minna JD Am J Respir Cell Mol Biol; 1990 Mar; 2(3):225-32. PubMed ID: 1968750 [TBL] [Abstract][Full Text] [Related]
8. Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation. Brodeur GM Prog Hematol; 1986; 14():229-56. PubMed ID: 3003796 [No Abstract] [Full Text] [Related]
9. Possible pathogenetic significance of specific chromosome abnormalities and activated proto-oncogenes in malignant diseases of man. Pedersen-Bjergaard J; Andersson P; Philip P Scand J Haematol; 1986 Feb; 36(2):127-37. PubMed ID: 3518040 [No Abstract] [Full Text] [Related]
10. Tumour markers and oncogenes in lung cancer. Mäkelä TP; Mattson K; Alitalo K Eur J Cancer; 1991; 27(10):1323-7. PubMed ID: 1659844 [No Abstract] [Full Text] [Related]
11. [Genetics and cancer]. Carnevale A; Salamanca-Gómez F; Lisker R; Orozco Orozco L Gac Med Mex; 1992; 128(2):107-25. PubMed ID: 1302207 [No Abstract] [Full Text] [Related]
13. [Lung cancer, smoking and genetic modifications]. Popescu I Pneumologia; 2008; 57(1):25-8. PubMed ID: 18543657 [TBL] [Abstract][Full Text] [Related]
14. A translational view of the molecular pathogenesis of lung cancer. Sato M; Shames DS; Gazdar AF; Minna JD J Thorac Oncol; 2007 Apr; 2(4):327-43. PubMed ID: 17409807 [TBL] [Abstract][Full Text] [Related]
15. Proto-oncogene and tumor suppressor gene involvement in human lymphomas. Saglio G; Benetton G; Cambrin GR; Scaravaglio P; Novero D; Palestro G Leukemia; 1991; 5 Suppl 1():7-11. PubMed ID: 1890871 [No Abstract] [Full Text] [Related]
16. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes. Bergh JC Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659 [TBL] [Abstract][Full Text] [Related]
17. Concepts in cancer biology. Brosman SA Prog Clin Biol Res; 1988; 260():137-65. PubMed ID: 3283758 [No Abstract] [Full Text] [Related]
18. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Osada H; Takahashi T Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883 [TBL] [Abstract][Full Text] [Related]
19. The molecular biology of lung cancer pathogenesis. Minna JD Chest; 1993 Apr; 103(4 Suppl):449S-456S. PubMed ID: 8462339 [TBL] [Abstract][Full Text] [Related]